Zydus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS
ZYDUS has four hundred and eleven approved drugs.
There is one US patent protecting ZYDUS drugs. There are twenty-eight tentative approvals on ZYDUS drugs.
Summary for Zydus
| US Patents: | 1 |
| Tradenames: | 329 |
| Ingredients: | 319 |
| NDAs: | 411 |
| Patent Litigation for Zydus: | See patent lawsuits for Zydus |
Drugs and US Patents for Zydus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms | DESVENLAFAXINE SUCCINATE | desvenlafaxine succinate | TABLET, EXTENDED RELEASE;ORAL | 204020-003 | Nov 30, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zydus Pharms Usa Inc | AMIODARONE HYDROCHLORIDE | amiodarone hydrochloride | TABLET;ORAL | 079029-001 | Sep 16, 2008 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zydus Pharms | BUSPIRONE HYDROCHLORIDE | buspirone hydrochloride | TABLET;ORAL | 078888-003 | Feb 7, 2014 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Zydus Lifesciences | SELEXIPAG | selexipag | TABLET;ORAL | 214302-006 | Dec 21, 2022 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Zydus Pharms | PINDOLOL | pindolol | TABLET;ORAL | 209866-002 | Aug 18, 2017 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Zydus Pharms | VARDENAFIL HYDROCHLORIDE | vardenafil hydrochloride | TABLET;ORAL | 208960-001 | Oct 31, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
International Patents for Zydus Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Philippines | 12016501686 | ⤷ Start Trial |
| South Africa | 201606075 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2015128877 | ⤷ Start Trial |
| India | 651MU2014 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Zydus Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1534390 | 91 3-2010 | Slovakia | ⤷ Start Trial | PRODUCT NAME: ELTROMBOPAG; REGISTRATION NO/DATE: EU/1/10/612/001 - EU/1/10/612/006 20100315 |
| 2498758 | 132020000000034 | Italy | ⤷ Start Trial | PRODUCT NAME: METFORMINA O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE; SAXAGLIPTIN O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE; DAPAGLIFLOZIN O UN SUO SOLVATO FARMACEUTICAMENTE ACCETTABILE.(QTRILMET); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/19/1401, 20191113 |
| 1453521 | 39/2015 | Austria | ⤷ Start Trial | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
| 2137537 | PA2014024 | Lithuania | ⤷ Start Trial | PRODUCT NAME: DIMETHYLIS FUMARAS; REGISTRATION NO/DATE: EU/1/13/837/001-002 20140130 |
| 2316456 | CR 2017 00062 | Denmark | ⤷ Start Trial | PRODUCT NAME: NALTREXON ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER NALTREXONHYDROCHLORID, OG BUPROPION ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER BUPROPIONHYDROCHLORID; REG. NO/DATE: EU/1/14/988 20150330 |
| 1304992 | SPC/GB13/061 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
